Evidence map›Paper›PMID 21099366›Full record

ArticleCancer biology & therapy2011

The Nrf2 transcription factor is a positive regulator of myeloid differentiation of acute myeloid leukemia cells.

Irene Bobilev, Victoria Novik, Itai Levi, Ofer Shpilberg, Joseph Levy, Yoav Sharoni, George P Studzinski, Michael Danilenko

Open access · bronzeAbstract read
In one paragraph

Article in Cancer biology & therapy, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Article
  3. Exploring the nexus of nuclear receptors in hematological malignancies.Cellular and molecular life sciences : CMLS · 2024
    Review
  4. Review
  5. Review
  6. Article
  7. The LPAInternational journal of molecular sciences · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Nucleotide Excision Repair and Vitamin D--Relevance for Skin Cancer Therapy.International journal of molecular sciences · 2016
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Irene BobilevDepartment of Clinical Biochemistry, Faculty of Health Sciences, Ben-Gurion University of the Negev, Petakh Tikva, Israel.
Victoria Novik
Itai Levi
Ofer Shpilberg
Joseph Levy
Yoav Sharoni
George P Studzinski
Michael Danilenko
Ben-Gurion University of the Negev · ILRabin Medical Center · ILSoroka Medical Center · ILThe Technological College of Beer Sheva · IL

Funding

Vitamin D Analogs as Adjuvants in Chemotherapy of CancerR01CA044722 · NCI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI STUDZINSKI, GEORGE P · 1987 to 2016
$3.5M
VITAMIN D PLANT ANTIOXIDANT SILIBININ IN LEUKEMIA TRANSLATIONAL STUDYR01CA117942 · NCI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI STUDZINSKI, GEORGE P · 2007 to 2010
$772k
NCI NIH HHS R01 CA044722NCI NIH HHS R01-CA-044722-20NCI NIH HHS R01 CA117942NCI NIH HHS R01-CA-117942-3
6 · The paper itself

Abstract

1α,25-dihydroxyvitamin D3 (1,25D) is a powerful differentiation agent, which has potential for treatment of acute myeloid leukemia (AML), but induces severe hypercalcemia at pharmacologically active doses. We have previously shown that carnosic acid (CA), the polyphenolic antioxidant from rosemary plant, markedly potentiates differentiation induced by low concentrations of 1,25D in human AML cell lines. Here, we demonstrated similar enhanced differentiation responses to the 1,25D/CA combination in primary leukemic cells derived from patients with AML, and determined the role of the Nrf2/antioxidant response element (Nrf2/ARE) pathway in these effects using U937 human monoblastic leukemia cells as the model. CA strongly transactivated the ARE-luciferase reporter gene, induced the ARE-responsive genes, NADP(H)-quinone oxidoreductase and the γ-glutamylcysteine synthetase heavy subunit, and elevated cellular glutathione levels. Interestingly, 1,25D potentiated the effects of CA on these activities. Stable transfection of wild-type (wt) Nrf2 resulted in the enhancement, while transfection of dominant-negative (dn) Nrf2 produced suppression of differentiation induced by the 1,25D/CA combination and, surprisingly, by 1,25D alone. These opposite effects were associated with a corresponding increase or decrease in vitamin D receptor and retinoid X receptor-α protein levels, and in vitamin D responsive element transactivation. Cells transfected with wtNrf2 and dnNrf2 also displayed opposing changes in the levels of the AP-1 family proteins (c-Jun and ATF2) and AP-1 transcriptional activity. Pretreatment with AP-1 decoy oligodeoxynucleotide markedly attenuated the differentiation in wtNrf2-transfected cells, suggesting that the pro-differentiation action of Nrf2 is mediated by functional AP-1. Our findings suggest that the Nrf2/ARE pathway plays an important part in the cooperative induction of myeloid leukemia cell differentiation by 1,25D and a plant polyphenol.

Indexed as

AbietanesCalcitriolCell DifferentiationGlutamate-Cysteine LigaseGlutathioneHL-60 CellsHumansLeukemia, Myeloid, AcuteNAD(P)H Dehydrogenase (Quinone)NF-E2-Related Factor 2Plant ExtractsReceptors, CalcitriolRetinoid X Receptor alphaTranscription Factor AP-1Tumor Cells, CulturedU937 CellsAbietanesCalcitriolGlutamate-Cysteine LigaseGlutathioneNAD(P)H Dehydrogenase (Quinone)NF-E2-Related Factor 2Plant ExtractsReceptors, CalcitriolRetinoid X Receptor alphasalvinTranscription Factor AP-1

Identifiers

PMID21099366
PMCPMC3047086
OpenAlexW1965438116

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.